CLINICAL TRIALS PROFILE FOR NEO-SYNALAR
✉ Email this page to a colleague
All Clinical Trials for NEO-SYNALAR
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01946386 ↗ | A Vasoconstriction Study With LEO 90100 | Completed | LEO Pharma | Phase 1 | 2013-09-01 | The purpose of this study is to compare the pharmacodynamic activity of LEO 90100 with Dermovate® cream, Dovobet® ointment, betamethasone dipropionate in LEO90100 vehicle, Synalar® ointment and LEO 90100 vehicle using a human skin blanching test. |
| NCT02168478 ↗ | Neo-Synalar Modified 48 Hour Patch Test | Completed | Noah Rosenberg, MD | Phase 4 | 2014-06-01 | A 48 hour patch test performed in healthy volunteers to determine the presensitization (pre-existing allergy) of Neo-Synalar (neomycin sulfate 0.5%(0.35% neomycin base), fluocinolone acetonide 0.025%) Cream . Subjects also receive a positive control (Sodium Lauryl Sulfate) and a negative control (Saline). The primary objective of this study is to determine if any subjects exhibit an allergic reaction which may be indicative of a pre-existing sensitization. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEO-SYNALAR
Condition Name
Clinical Trial Locations for NEO-SYNALAR
Trials by Country
Clinical Trial Progress for NEO-SYNALAR
Clinical Trial Phase
Clinical Trial Sponsors for NEO-SYNALAR
Sponsor Name
